Global Cord Blood (CORBF) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Global Cord Blood Corporation, in provisional liquidation, has faced setbacks with two inquorate extraordinary general meetings, leading to a court summons for the approval of the Joint Provisional Liquidators’ remuneration. Shareholders have raised questions regarding the remuneration terms, with a hearing set for July 30, 2024, to seek court sanction for the JPLs’ fees totaling over $10 million incurred during the previous year. Shareholders are encouraged to submit further comments or appear at the hearing to express their support or opposition.
For further insights into CORBF stock, check out TipRanks’ Stock Analysis page.